MISSION VIEJO, Calif.--(BUSINESS WIRE)--Aeolus Pharmaceuticals, Inc. (OTCBB: AOLS) announced today financial results for the three months ended December 31, 2009. The Company reported a net loss of $15,276,000, or $0.33 per basic share, compared to a loss of $459,000, or $0.01 per basic share, for the three months ended December 31, 2008. The first quarter 2009 results include non-cash financing and change in valuation charges of $13,860,000. During the three months ended December 31, 2009, the Company’s net cash used in operating activities was $389,000 compared to $606,000 for the three months ended December 31, 2008. Management believes that cash flow from operations is a better indication of the financial performance of the Company during the quarter.
